Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study.
Saved in:
| Title: | Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study. |
|---|---|
| Authors: | Stein, Cy A.1, Levin, Richard2, Given, Robert3, Higano, Celestia S.4, Nemeth, Paul5 pnemeth@churchillpharma.com, Bosch, Bill5, Chapas-Reed, Jillian5, Dreicer, Robert6 |
| Source: | Urologic Oncology. Feb2018, Vol. 36 Issue 2, p81.e9-81.e16. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 127469868 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Stein%2C+Cy+A%2E%22">Stein, Cy A.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Levin%2C+Richard%22">Levin, Richard</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Given%2C+Robert%22">Given, Robert</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Higano%2C+Celestia+S%2E%22">Higano, Celestia S.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Nemeth%2C+Paul%22">Nemeth, Paul</searchLink><relatesTo>5</relatesTo><i> pnemeth@churchillpharma.com</i><br /><searchLink fieldCode="AR" term="%22Bosch%2C+Bill%22">Bosch, Bill</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Chapas-Reed%2C+Jillian%22">Chapas-Reed, Jillian</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Dreicer%2C+Robert%22">Dreicer, Robert</searchLink><relatesTo>6</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Urologic+Oncology%22">Urologic Oncology</searchLink>. Feb2018, Vol. 36 Issue 2, p81.e9-81.e16. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=127469868 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.urolonc.2017.10.018 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: 81.e9 Titles: – TitleFull: Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Stein, Cy A. – PersonEntity: Name: NameFull: Levin, Richard – PersonEntity: Name: NameFull: Given, Robert – PersonEntity: Name: NameFull: Higano, Celestia S. – PersonEntity: Name: NameFull: Nemeth, Paul – PersonEntity: Name: NameFull: Bosch, Bill – PersonEntity: Name: NameFull: Chapas-Reed, Jillian – PersonEntity: Name: NameFull: Dreicer, Robert IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: Feb2018 Type: published Y: 2018 Identifiers: – Type: issn-print Value: 10781439 Numbering: – Type: volume Value: 36 – Type: issue Value: 2 Titles: – TitleFull: Urologic Oncology Type: main |
| ResultId | 1 |